Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Small Cell Lung Carcinoma × Standard of Care × Clear all

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Neoplasm Metastasis 7 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Urinary Bladder Neoplasms 5 Leukemia, Myeloid, Acute 5 Colorectal Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Lung Neoplasms 4 Triple Negative Breast Neoplasms 3 Ovarian Neoplasms 3 Mouth Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Ovarian Epithelial 3 Ureteral Neoplasms 2 Recurrence 2 Oropharyngeal Neoplasms 2 Melanoma 2 Laryngeal Neoplasms 2 Glioblastoma 2 Gastrointestinal Neoplasms 2 Carcinoma 2 COVID-19 2 Brain Neoplasms 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tonsillar Neoplasms 1

Interventions

Etoposide 70 Carboplatin 60 Cisplatin 40 Topotecan 26 durvalumab 25 atezolizumab 18 Radiotherapy 18 Irinotecan 18 Paclitaxel 15 Nivolumab 15 apatinib 14 anlotinib 12 Drug Therapy 12 pembrolizumab 9 Platinum 9 toripalimab 8 Bevacizumab 8 Radiosurgery 7 PM 01183 7 Ipilimumab 7 tislelizumab 6 Gemcitabine 6 olaparib 5 amrubicin 5 Temozolomide 5 Sunitinib 5 Pemetrexed 5 Docetaxel 5 Albumin-Bound Paclitaxel 5 irinotecan sucrosofate 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02200081 2018-11-15

IMPULSE

Mologen AG

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡